What Country Has the Highest Rate of Celiac Disease?

Finland consistently reports the highest national celiac disease prevalence of any country with large-scale screening data, with adult rates reaching about 2.4% in population-based studies. But “highest rate” depends heavily on who gets tested and how, and the honest picture is more complicated than a single country ranking. Some smaller or displaced populations show even higher figures, enormous portions of the world have never been screened at all, and the gap between diagnosed and undiagnosed celiac disease is so wide that the true global map remains incomplete.

Finland’s Numbers and Why They Stand Out

A centralized mass screening project across several European countries found that celiac disease prevalence in adults aged 30 to 64 was 2.4% in Finland, compared with 0.7% in Italy and just 0.3% in Germany.¹ An earlier screening study of Finnish schoolchildren estimated a prevalence of at least one case in every 99 children, roughly 1%.² Those figures are striking given that the pooled global average is around 1.4% by blood-test screening and about 0.7% when confirmed by intestinal biopsy.³

Finland’s high numbers are not an accident of one study. The country has invested in large population screens, has strong medical registries, and its doctors have a high index of suspicion for celiac disease. That combination means more cases get caught. Whether Finland truly has the most celiac disease in the world, or simply finds more of it than other countries do, is a question that runs through this entire topic.

The Saharawi Exception

If you look beyond conventional nation-states, the highest celiac disease rate ever recorded belongs to the Saharawi people, a population originally from Western Sahara living largely in refugee camps in Algeria. Studies of Saharawi children have estimated a prevalence of about 5.6%, roughly four times the global seroprevalence average.⁴ That figure is so far above any national estimate that it demands explanation.

Several factors converge. The Saharawi population has a high frequency of the genetic variants that predispose people to celiac disease, particularly HLA-DQ2. At the same time, food aid in the camps relies heavily on wheat flour and wheat-based products, so gluten exposure is intense and begins early. The combination of strong genetic susceptibility and high dietary gluten appears to create an unusually fertile ground for the disease. The Saharawi case also illustrates that celiac disease is not exclusively a Northern European condition, even though the public perception leans that way.

The Diagnostic Iceberg

The biggest complication in ranking countries is underdiagnosis. Most people with celiac disease do not know they have it. A large Norwegian population study found a total biopsy-confirmed prevalence of 1.5%, and among those cases the ratio of newly discovered, previously undiagnosed people to those already known to have celiac disease was 1.2 to 1.⁵ In other words, for every person already diagnosed, there was more than one additional person walking around with confirmed celiac disease who had never been told. That was in Norway, a country with excellent healthcare access. In regions with fewer gastroenterologists, less awareness, and limited screening infrastructure, the undiagnosed fraction is likely far larger.

Socioeconomic status compounds the problem. A UK study found that the rate of celiac disease diagnosis in children from the least deprived areas was 80% higher than in children from the most deprived areas.⁶ That gap does not reflect biology. It reflects who gets tested. Patients with less typical symptoms are also less likely to be diagnosed if they come from lower socioeconomic backgrounds.⁷ This means that wherever healthcare access is uneven, official celiac prevalence numbers are skewed downward for disadvantaged communities.

The upshot is that any global ranking of celiac disease rates is really a ranking of testing intensity combined with underlying biology. Finland looks like the leader partly because it screens aggressively. Countries that test less will always appear to have less disease, whether or not that is true.

Where Celiac Disease Was Once Thought Rare

For decades, celiac disease was considered a European problem. That perception has been thoroughly dismantled. Once serological screening tools became widely available, researchers began finding celiac disease at rates comparable to Western countries across the Middle East, North Africa, and parts of South Asia.⁸

In Iran, for instance, celiac disease has been found at significant rates in both the general population and in people with conditions like type 1 diabetes or irritable bowel syndrome.⁹ The prevalence of celiac disease in low-risk populations across the Middle East and North Africa is broadly similar to that of Western countries, while high-risk groups like people with type 1 diabetes can show rates between 3% and 20%.¹⁰ A mass screening study in Tunisian schoolchildren found that roughly 1 in 45 tested positive for celiac-related antibodies, and biopsies confirmed the disease in the majority of double-positive cases.¹¹

India presents a particularly interesting pattern. A large multicenter study of over 23,000 healthy adults found that celiac autoantibody prevalence in northern India was about 1.2%, while in southern India it was only 0.1%.¹² That ten-fold regional difference within a single country correlated with wheat intake, not genetic background. Northern Indians eat far more wheat than southern Indians, who rely more on rice.¹³

East Asia remains a genuine low-prevalence zone. A systematic review of the Asia-Pacific region found the lowest seroprevalence in East Asia at just 0.06%, compared with 1.4% in the Middle East and 1.2% in South Asia.¹⁴ Very few celiac disease cases have been documented in ethnic Chinese and Japanese populations, and the genetic variants that predispose to celiac disease occur at much lower frequencies in those groups.¹⁵

Why Geography Matters Beyond Genetics

Celiac disease requires two things at a minimum: genetic susceptibility and exposure to gluten. Almost all people with celiac disease carry specific immune system gene variants, particularly HLA-DQ2 or HLA-DQ8. But carrying those genes is necessary, not sufficient. Roughly a fifth of people in Western Europe carry HLA-DQ2, yet only a fraction develop celiac disease. Something else in the environment tips the balance.

The genetic piece does explain some of the global variation. HLA-DQ2 occurs in about 5 to 20% of Western Europeans but only 5 to 10% of Chinese and sub-Saharan African populations.¹⁵ Among confirmed celiac patients, these genetic markers are found at very high rates: around 91% of celiac patients in the UK express DQ2, and similar proportions appear across Arab populations.¹⁶ Where these gene variants are rare, celiac disease is rare. That is a large part of why East Asia has such low rates.

Wheat consumption matters on a broad scale. At the continent level, wheat intake and celiac prevalence are highly correlated, but the correlation weakens when you compare countries directly, suggesting that other factors intervene at the national level.¹⁷ Another systematic review found a small but statistically real association between wheat supply per capita and celiac disease prevalence.¹⁸ So wheat consumption sets the stage, especially in populations genetically primed for the disease, but you cannot predict a country’s celiac rate from its bread consumption alone.

The Latitude Gradient

One of the more unexpected patterns in celiac epidemiology is that prevalence rises with distance from the equator. A meta-analysis of 128 studies across 40 countries found that celiac disease was more common at higher latitudes. People living between 61° and 70° north had roughly 2.3 times the risk compared with those at 41° to 50° north.¹⁹ Within the United States specifically, people living at or above 40° north had over five times the odds of celiac disease compared with those below 35° north, even after adjusting for race, ethnicity, income, and body weight.²⁰

The leading hypothesis involves vitamin D. Higher latitudes mean less ultraviolet sunlight, which means less vitamin D synthesis in the skin. Vitamin D plays a role in immune regulation, and lower levels could make autoimmune activation more likely. This would help explain why Scandinavian countries, which sit at high latitudes and have limited winter sunlight, cluster near the top of celiac prevalence rankings. It also fits Finland’s position: Helsinki sits at nearly 60° north. The latitude link is not proof that vitamin D deficiency causes celiac disease, but it is a consistent and robust finding across studies that researchers take seriously.

Rates Are Climbing Everywhere

Celiac disease is not holding steady. A systematic review pooling data from multiple decades found that the incidence has been increasing by about 7.5% per year.²¹ Some of that increase is better detection: more doctors test for it now, and the blood tests have improved. But studies that compare stored blood samples from past decades against current samples show that the actual underlying prevalence has risen, not just the rate of diagnosis.²²

Whatever environmental factors interact with genetic susceptibility, they appear to be intensifying. The timeline rules out genetics as the driver, because gene pools do not shift that fast. Something about the modern environment, whether it is changes in infant feeding, altered gut bacteria, increased infections, or factors we have not identified yet, is pushing more genetically susceptible people over the threshold into active disease.

Sweden’s Infant Feeding Epidemic

One of the most dramatic illustrations of how environment shapes celiac rates comes from Sweden. Beginning in the mid-1980s, Sweden experienced a sharp spike in celiac disease diagnoses among young children, sometimes called the Swedish celiac epidemic. Researchers traced about half of the increase to a change in how infants were introduced to gluten: a shift toward giving babies larger amounts of gluten-containing foods after breastfeeding had already ended.²³ This was partly driven by changes in national dietary guidelines and in the composition of commercially produced baby foods.

When Sweden reversed course and updated its infant feeding recommendations, celiac diagnoses in young children declined. The episode showed that national policy decisions about something as mundane as baby food formulations can meaningfully alter the incidence of an autoimmune disease at the population level. It also reinforced that the timing, amount, and context of early gluten introduction all matter, not just whether a child eats wheat.

Enterovirus and the Infection Connection

Researchers have increasingly focused on viral infections as a potential trigger for celiac disease in genetically susceptible people. Two large birth cohort studies have found that enterovirus infections, a very common group of gut viruses, are associated with later development of celiac disease. One study found that children who went on to develop celiac disease were about twice as likely to have had enterovirus detected in stool samples before celiac antibodies appeared, particularly when the viral load was high or the infection lingered for more than two months.²⁴ Another birth cohort study reported an even stronger association, with roughly half of children who developed celiac disease having had enterovirus infections in the two years before antibody development, compared with a quarter of control children.²⁵

The association was specific to enteroviruses. Adenovirus, another common gut virus, showed no link to celiac disease.²⁴ The timing also mattered: infections that occurred after gluten had been introduced to the diet carried the risk, while those occurring before gluten exposure did not. This suggests a model where a gut viral infection at the wrong moment may prime the immune system to react to gluten proteins, setting off the autoimmune cascade in a child who was already genetically vulnerable. If confirmed by further research, this could partially explain why celiac rates vary so much even among populations with similar genetics and diet.

Gut Bacteria and Celiac Disease

The gut microbiome has emerged as another piece of the puzzle. A cross-cohort analysis comparing the gut bacteria of people with celiac disease against healthy controls found consistent patterns: people with or developing celiac disease had reduced levels of several beneficial bacterial species, including members of the Faecalibacterium and Prevotella genera, along with Akkermansia muciniphila. At the same time, certain other species were enriched in people heading toward celiac disease.²⁶

Whether these microbial shifts are a cause, a consequence, or a bystander effect remains unclear. It is plausible that a disrupted microbiome contributes to the loss of immune tolerance to gluten, or that the intestinal inflammation from celiac disease reshapes which bacteria thrive. The research is still in the observational phase, but it adds another environmental variable that could differ meaningfully between countries and help explain geographic variation in celiac rates. Populations with different diets, different antibiotic use patterns, and different sanitation infrastructure will have different gut microbial profiles, and those differences may prove relevant.

Why East Asia Stays Low

If you are wondering why some parts of the world barely see celiac disease at all, East Asia is the clearest example. Only about two dozen ethnic Chinese and Japanese celiac patients had been documented in the English medical literature as of one major systematic review.¹⁵ The pooled seroprevalence in East Asia sits at roughly 0.06%, which is an order of magnitude below the global average.¹⁴

The explanation is straightforward on two fronts. East Asian populations carry HLA-DQ2 at very low frequencies, so few people have the genetic susceptibility in the first place. Simultaneously, traditional diets in China, Japan, and Korea center on rice rather than wheat. Without the genetic predisposition and without significant gluten exposure, the disease has little opportunity to develop. The question going forward is whether rising wheat consumption in these regions, driven by urbanization and Western dietary influence, will produce a new wave of celiac disease among the small but nonzero fraction of the population that does carry susceptibility genes. Researchers are watching, but so far the numbers remain very low.

How Diagnostic Methods Shift the Numbers

Part of the reason country-level comparisons are unreliable is that different studies use different diagnostic thresholds. Celiac disease can be detected through blood antibody tests, confirmed through intestinal biopsy, or diagnosed through a combination of both. Blood tests cast a wider net and tend to produce higher prevalence estimates. Biopsy narrows the count but misses people who have early-stage damage or patchy intestinal involvement.

The global meta-analysis that reported 1.4% seroprevalence and 0.7% biopsy-confirmed prevalence captured this gap perfectly: the rate roughly halved when a biopsy requirement was added.³ A country relying on biopsy-based diagnosis will always appear to have less celiac disease than one that counts positive antibody tests. Some pediatric guidelines in Europe now allow diagnosis without biopsy if antibody levels are sufficiently high, which has changed the diagnostic landscape for children in particular. When comparing prevalence between countries, the testing method used matters as much as the biology of the population being tested.

Variable diagnostic practices also explain why prevalence and incidence figures rose so dramatically in recent decades. The introduction of reliable antibody blood tests in the 1980s and 1990s transformed celiac disease from a rare pediatric diagnosis into a recognized common condition of all ages. Countries that adopted serological screening early, like Finland and Sweden, registered their prevalence spikes sooner. Countries that still rely primarily on clinical suspicion and biopsy continue to report lower rates, though that says more about their testing habits than their population’s actual disease burden.

1
PubMed. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project
2
PubMed. Prevalence of Celiac Disease among Children in Finland
3
PubMed. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis
4
PubMed Central. Celiac disease seropositivity in Saharawi children: a follow-up and family study
5
PubMed Central. The Prevalence and Rate of Undiagnosed Celiac Disease in an Adult General Population, the Trøndelag Health Study, Norway
6
Archives of Disease in Childhood. Socioeconomic variation in the incidence of childhood coeliac disease in the UK
7
PubMed Central. The association between socioeconomic status and the symptoms at diagnosis of celiac disease: a retrospective cohort study
8
PubMed. Coeliac disease in developing countries: Middle East, India and North Africa
9
PubMed. Coeliac disease in Middle Eastern countries: a challenge for the evolutionary history of this complex disorder?
10
PubMed Central. Celiac disease in Middle Eastern and North African countries: a new burden?
11
European Journal of Gastroenterology & Hepatology. Prevalence of celiac disease in Tunisia: mass-screening study in schoolchildren
12
The American Journal of Gastroenterology. Prevalence of Adult Celiac Disease in India: Regional Variations and Associations
13
PubMed Central. Emergence of Celiac Disease and Gluten-related Disorders in Asia
14
Scientific Reports. Prevalence of celiac disease in low and high risk population in Asia–Pacific region: a systematic review and meta-analysis
15
PubMed. Systematic review: worldwide variation in the frequency of coeliac disease and changes over time
16
PubMed Central. Meta-Analysis and Systematic Review of HLA DQ2/DQ8 in Adults with Celiac Disease
17
PubMed. Wheat consumption and prevalence of celiac disease: Correlation from a multilevel analysis
18
PubMed. Relationship between gluten availability and celiac disease prevalence: A geo-epidemiologic systematic review
19
PubMed. Latitude and Celiac Disease Prevalence: A Meta-Analysis and Meta-Regression
20
PubMed Central. Lower Prevalence of Celiac Disease and Gluten-Related Disorders in Persons Living in Southern vs Northern Latitudes of the United States
21
PubMed. Incidence of Celiac Disease Is Increasing Over Time: A Systematic Review and Meta-analysis
22
PubMed. Patient and Community Health Global Burden in a World With More Celiac Disease
23
PubMed. The Swedish epidemic of coeliac disease explored using an epidemiological approach–some lessons to be learnt
24
BMJ. Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort
25
PubMed Central. Enterovirus Infections Are Associated With the Development of Celiac Disease in a Birth Cohort Study
26
Communications Medicine. Comprehensive cross-cohort analysis reveals global gut microbiome signatures of celiac disease